Derivatives of triazines and uracils, their preparation and their application in human therapeutics

A compound of formula I wherein:

• W represents nitrogen
• R1 and R2 represent:
• a hydrogen or a linear or branched C1-C7 alkyl or alkenyl radical, with the proviso that R1 and R2 are not simultaneously hydrogen, or,
• a C1-C3 alkyl radical substituted with groups selected from:
• trifluoromethyl, nitrile, hydroxy, C1-C3 alkoxy, C3-C6 alkoxyalkoxy, indolyl, thiophenyl, oxothiophenyl, C1-C3 N-alkyl or N-dialkylcarbamoyl groups or,
• phenyl or aroyl or benzyloxy or N-arylcarbamoyl groups, for which the phenyl ring is optionally substituted with one or more groups selected from linear or branched C1-C4 alkyl, nitro groups, or halogen atoms,
• a phenyl or pyridyl or naphthyl or thiophenyl group optionally substituted with one or more groups selected from halogen atoms, nitro, nitrile, trifluoromethyl, vinyl, methylsulfanyl, linear or branched C1-C4 alkyl, linear or branched C1-C3 alkoxy, phenyl, C1-C3 N-mono- or di-alkylcarbamoyl, or C1-C4 alkylcarboxamido groups,
• a C5-C6 2-oxocycloalkyl radical optionally fused with a phenyl group,
• m and n are equal to 1
• V represents CH2
• X—Y represents —N—(C═O)—, —CH—CH2—, —CH—O—, —CH—(C═O)—,
• Z represents a phenyl group substituted with one or more trifluoromethyl groups, halogen atoms, linear or branched C1-C4 alkyl, linear or branched C1-C3 alkoxy groups.